| UniProt ID | HYEP_HUMAN | |
|---|---|---|
| UniProt AC | P07099 | |
| Protein Name | Epoxide hydrolase 1 | |
| Gene Name | EPHX1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 455 | |
| Subcellular Localization |
Microsome membrane Single-pass type III membrane protein . Endoplasmic reticulum membrane Single-pass type III membrane protein . |
|
| Protein Description | Biotransformation enzyme that catalyzes the hydrolysis of arene and aliphatic epoxides to less reactive and more water soluble dihydrodiols by the trans addition of water (By similarity). May play a role in the metabolism of endogenous lipids such as epoxide-containing fatty acids. [PubMed: 22798687] | |
| Protein Sequence | MWLEILLTSVLGFAIYWFISRDKEETLPLEDGWWGPGTRSAAREDDSIRPFKVETSDEEIHDLHQRIDKFRFTPPLEDSCFHYGFNSNYLKKVISYWRNEFDWKKQVEILNRYPHFKTKIEGLDIHFIHVKPPQLPAGHTPKPLLMVHGWPGSFYEFYKIIPLLTDPKNHGLSDEHVFEVICPSIPGYGFSEASSKKGFNSVATARIFYKLMLRLGFQEFYIQGGDWGSLICTNMAQLVPSHVKGLHLNMALVLSNFSTLTLLLGQRFGRFLGLTERDVELLYPVKEKVFYSLMRESGYMHIQCTKPDTVGSALNDSPVGLAAYILEKFSTWTNTEFRYLEDGGLERKFSLDDLLTNVMLYWTTGTIISSQRFYKENLGQGWMTQKHERMKVYVPTGFSAFPFELLHTPEKWVRFKYPKLISYSYMVRGGHFAAFEEPELLAQDIRKFLSVLERQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 47 | Phosphorylation | SAAREDDSIRPFKVE HCCCCCCCCCCEECC | 32.58 | 28857561 | |
| 52 | Ubiquitination | DDSIRPFKVETSDEE CCCCCCEECCCCHHH | 41.67 | 21890473 | |
| 52 | Ubiquitination | DDSIRPFKVETSDEE CCCCCCEECCCCHHH | 41.67 | 21890473 | |
| 55 | Phosphorylation | IRPFKVETSDEEIHD CCCEECCCCHHHHHH | 44.45 | 25072903 | |
| 56 | Phosphorylation | RPFKVETSDEEIHDL CCEECCCCHHHHHHH | 29.53 | 25072903 | |
| 91 | 2-Hydroxyisobutyrylation | GFNSNYLKKVISYWR CCCHHHHHHHHHHHH | 34.33 | - | |
| 91 | Ubiquitination | GFNSNYLKKVISYWR CCCHHHHHHHHHHHH | 34.33 | - | |
| 92 | 2-Hydroxyisobutyrylation | FNSNYLKKVISYWRN CCHHHHHHHHHHHHH | 42.05 | - | |
| 92 | Ubiquitination | FNSNYLKKVISYWRN CCHHHHHHHHHHHHH | 42.05 | - | |
| 95 | Phosphorylation | NYLKKVISYWRNEFD HHHHHHHHHHHHCCC | 22.94 | 26437602 | |
| 104 | 2-Hydroxyisobutyrylation | WRNEFDWKKQVEILN HHHCCCHHHHHHHHH | 34.86 | - | |
| 105 | Ubiquitination | RNEFDWKKQVEILNR HHCCCHHHHHHHHHC | 56.15 | - | |
| 117 | Methylation | LNRYPHFKTKIEGLD HHCCCCHHHEECCEE | 45.96 | - | |
| 119 | Methylation | RYPHFKTKIEGLDIH CCCCHHHEECCEEEE | 39.07 | - | |
| 131 | Acetylation | DIHFIHVKPPQLPAG EEEEEEECCCCCCCC | 36.50 | 20167786 | |
| 165 | Phosphorylation | YKIIPLLTDPKNHGL HHHHHHHCCCCCCCC | 58.92 | 24719451 | |
| 168 | Ubiquitination | IPLLTDPKNHGLSDE HHHHCCCCCCCCCCC | 65.47 | - | |
| 168 | 2-Hydroxyisobutyrylation | IPLLTDPKNHGLSDE HHHHCCCCCCCCCCC | 65.47 | - | |
| 173 | Phosphorylation | DPKNHGLSDEHVFEV CCCCCCCCCCCEEEE | 45.61 | 24275569 | |
| 196 | Ubiquitination | GFSEASSKKGFNSVA CCCHHHCCCCCCHHH | 55.19 | - | |
| 197 | Ubiquitination | FSEASSKKGFNSVAT CCHHHCCCCCCHHHH | 71.35 | - | |
| 204 | Phosphorylation | KGFNSVATARIFYKL CCCCHHHHHHHHHHH | 17.82 | - | |
| 210 | Acetylation | ATARIFYKLMLRLGF HHHHHHHHHHHHHCC | 19.37 | 25825284 | |
| 283 | Phosphorylation | ERDVELLYPVKEKVF HHHHHHHHCHHHHHH | 20.71 | 28152594 | |
| 286 | Ubiquitination | VELLYPVKEKVFYSL HHHHHCHHHHHHHHH | 47.52 | 21906983 | |
| 286 | 2-Hydroxyisobutyrylation | VELLYPVKEKVFYSL HHHHHCHHHHHHHHH | 47.52 | - | |
| 288 | Ubiquitination | LLYPVKEKVFYSLMR HHHCHHHHHHHHHHH | 31.74 | - | |
| 288 | Ubiquitination | LLYPVKEKVFYSLMR HHHCHHHHHHHHHHH | 31.74 | - | |
| 291 | Phosphorylation | PVKEKVFYSLMRESG CHHHHHHHHHHHHHC | 12.13 | 21253578 | |
| 292 | Phosphorylation | VKEKVFYSLMRESGY HHHHHHHHHHHHHCC | 12.29 | 24275569 | |
| 295 | Methylation | KVFYSLMRESGYMHI HHHHHHHHHHCCEEE | 39.98 | - | |
| 297 | Phosphorylation | FYSLMRESGYMHIQC HHHHHHHHCCEEEEE | 25.51 | - | |
| 299 | Phosphorylation | SLMRESGYMHIQCTK HHHHHHCCEEEEECC | 8.52 | - | |
| 339 | Phosphorylation | WTNTEFRYLEDGGLE CCCCCEEEECCCCCC | 21.55 | 21253578 | |
| 361 | Phosphorylation | LLTNVMLYWTTGTII HHHHHHHHHHHCCHH | 5.21 | - | |
| 375 | 2-Hydroxyisobutyrylation | ISSQRFYKENLGQGW HHCHHHHHHHCCCCC | 37.10 | - | |
| 386 | Ubiquitination | GQGWMTQKHERMKVY CCCCCCCCCCCEEEE | 37.96 | 2190698 | |
| 386 | Acetylation | GQGWMTQKHERMKVY CCCCCCCCCCCEEEE | 37.96 | 25825284 | |
| 386 | 2-Hydroxyisobutyrylation | GQGWMTQKHERMKVY CCCCCCCCCCCEEEE | 37.96 | - | |
| 393 | Phosphorylation | KHERMKVYVPTGFSA CCCCEEEEECCCCCC | 8.66 | - | |
| 408 | Phosphorylation | FPFELLHTPEKWVRF CCHHHHCCCCCCEEC | 32.86 | - | |
| 417 | Phosphorylation | EKWVRFKYPKLISYS CCCEECCCCCCEEEE | 11.68 | 21406692 | |
| 422 | Phosphorylation | FKYPKLISYSYMVRG CCCCCCEEEEEEECC | 20.61 | 20068231 | |
| 423 | Phosphorylation | KYPKLISYSYMVRGG CCCCCEEEEEEECCC | 9.23 | 20068231 | |
| 424 | Phosphorylation | YPKLISYSYMVRGGH CCCCEEEEEEECCCC | 10.44 | 21406692 | |
| 425 | Phosphorylation | PKLISYSYMVRGGHF CCCEEEEEEECCCCE | 7.44 | 20068231 | |
| 447 | Acetylation | LLAQDIRKFLSVLER HHHHHHHHHHHHHHH | 51.49 | 27178108 | |
| 450 | Phosphorylation | QDIRKFLSVLERQ-- HHHHHHHHHHHHC-- | 27.99 | 25072903 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HYEP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HYEP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HYEP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ECHA_HUMAN | HADHA | physical | 26344197 | |
| TMEDA_HUMAN | TMED10 | physical | 26344197 | |
| TMX1_HUMAN | TMX1 | physical | 26344197 | |
| RAB34_HUMAN | RAB34 | physical | 28514442 | |
| MFSD8_HUMAN | MFSD8 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00516 | Isolated orofacial clefts, including: Cleft lip with or without cleft palate; Cleft palate | |||||
| OMIM Disease | ||||||
| 0000269|PubMed | Note=In some populations, the high activity haplotype tyr113/his139 is overrepresented among women suffering from pregnancy-induced hypertension (pre-eclampsia) when compared with healthy controls. {ECO | |||||
| 607748 | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...